The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Abstract

SummaryNatural killer cells express clonally distributed receptors specific for major histocompatibility complex class I molecules. The human leukocyte antigen (HLA)-C-specific receptors have been molecularly identified and cloned. They exist not only as inhibitory (p58) but also as activatory (1050) receptors. Here we show that p50 and p58 are highly homologous in their extracellular regions formed by two Ig-like domains. In contrast, major differences exist in their transmembrane and cytoplasmic portions. Whereas p58 displays a 76-84-amino acid cytoplasmic tail containing an unusual antigen receptor activation motif, p50 is characterized by a shorter 39-amino acid tail. In addition, whereas p58 has a nonpolar transmembrane portion, p50 contains the charged amino acid Lys. These data strongly suggest that receptors with identical HLA-C allele specificity can mediate functions of opposite sign owing to their different transmembrane/cytoplasmic portions.T he cytolytic activity of NK cells is regulated by several clonally distributed inhibitory receptors specific for different groups of HLA class I andes. Interaction between these NK receptors and HLA class I molecules leads to inhibition of the NK-mediated target cell lysis (1--4). The receptors specific for two distinct groups of HLA-C alleles have been molecularly identified as p58 molecules, which react with either GL183 (5) or EB6 mAb (6). p58-encoding genes have recently been isolated and cloned (7). They encode for type 1 transmembrane proteins, which belong to the Ig supeffamily. They are characterized by two extracellular Ig-hke domains and display a high level of sequence homology. Recently, additional 50-kD molecular forms of EB6 or GL183 mAb-reactive receptors have been identified. They display the same HLA-C allele specificity of the corresponding p58 receptors but mediate NK cell triggering rather than inhibition (8). p50 receptors were found to be expressed only in some donors and to display a clonal distribution. Importantly, single NK cells did not coexpress p58 and p50 receptors with an identical HLA-C specificity (8). The protein backbone of p58 or p50 molecules has been shown to be 42 and 36 kD, respectively, after deglycosylation. These data, together with identical HLA-C specificity and mAb reactivity, suggested that p58 and p50 could be homologous in their extracellular domains but different in their intracellular portions. Cloning of several p58-homologous genes revealed the existence of molecules displaying cytoplasmic tails of different length. Here we show that, different from p58, the activatory p50 receptors are characterized by a short intracytoplasmic tail associated with a transmembrane portion containing a polar residue. Materials and Methods Isolation of EB6 + or GL183 § NK Clones and Definition of theFunction of their Receptors. EB6 § or GL183 § NK cell clones were isolated as previously described (4). Screening of clones for the expression of triggering (p50) or inhibitory (p58) receptors was performed by cytolytic tests using P...

Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes

“…7 The KIR complex also codes for activating receptors of unclear physiological role, some of which are structurally homologous to certain inhibitory KIR. 8 Several of those activating KIR are recognized by the same monoclonal antibodies as their inhibitory counterparts, and appear to interact with the identical ligands, albeit with much lower affinity. 9,10 In contrast, other activating KIR, which have no inhibitory homologues, 11 are detected by none of the available monoclonal antibodies, and their structures, ligands and functions remain unknown or only hypothetical.…”

Cobalt-mediated Dimerization of the Human Natural Killer Cell Inhibitory Receptor

“…All the inhibitory KIR2DL receptors may therefore have the potential to form dimers in the presence of Co 2ϩ . Although the activating receptor KIR2DS4 does not have an amino-terminal His, and does not bind Co 2ϩ , several other activating KIR2D molecules (KIR2DS, also known as p50) (17), including KIR2DS2, KIR2DS3, and KIR2DS5 (11,(17)(18)(19), all contain the initial His. This suggests that some activating receptors may also be dimerized by Co 2ϩ .…”

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients

“…[6][7][8] Activating receptors include: the natural cytotoxicity receptors (NCRs) NKp46, 9,10 NKp44 11 and NKp30, 12 the ligands of which have not yet been identified; the C-type lectin NKG2D 13 receptor, which binds to MHC class-I chain-related molecule (MIC) 14 and UL-16-binding protein (ULBP), 15,16 and activating KIRs. 17 Once activated, NK cells release granzymes and perforin to induce apoptosis of the target cells. [18][19][20] The graft-versus-leukemia (GvL) 21 effect mediated by donor-derived immune effectors early after hematopoietic stem cell transplantation (HSCT) may eradicate residual tumor cells and may be crucial in preventing disease relapse.…”